FAIR TRIALS INTERNATIONAL
(Company limited by guarantee no. 07135273 registered charity no. 1134586)
REPORT AND FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2024
FAIR TRIALS INTERNATIONAL
COMPANY LIMITED BY GUARANTEE NO. 07135273 registered charity number 1134586 REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
| CONTENTS | Page |
|---|---|
| Charity Reference and Administrative Details | |
| Trustees' Annual Report | 2 |
| Consolidated Statement of Financial Activities | 10 |
| Consolidated and Parent Balance Sheets | 11 |
| Consolidated Statement of Cash Flows | 12 |
| Notes to the Financial Statements | 13 |
FAIR TRIALS INTERNATIONAL
REFERENCE AND ADMINISTRATIVE DETAILS FOR THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2024
Status The organisation is a private company limited by guarantee Company number 07135273 Charity number 1134586 Board of Trustees Eric Kolodner (Chair) Matthew Bruce (Resigned September 2023) Robert Scott Amy Jeffress Kate Steele (Resigned November 2024) Morris Lipson Stephen Muers Martha Dark (Resigned January 2024) Jasvinder Nakhwal (Resigned March 2024) Chief Executive Neil Jeffery (Appointed July 2023, Resigned November 2024) Bankers Barclays Bank PLC 19 Fleet Street London EC4Y 1M Registered office 5 Castle Road London NW1 8PR
1
TRUSTEES' ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2024
The Trustees of Fair Trials International (the "Charity") are pleased to present their report together with the consolidated financial statements of the Charity for the year ended 31 March 2024. This report documents the Charity's activities during this period and notes significant developments, including the decision to wind down the Charity’s operations as of November 2024. Fair Trials Europe will continue to operate with funding from the Oak Foundation and the European Commission. The Trustees have adopted the provisions of the Statement of Recommended Practice (SORP) "Accounting and Reporting by Charities" (FRS 102) in preparing the annual report and financial statements of the Charity.
Constitutional, governance and management
In 2010, the Charity was incorporated and registered in England and Wales as a company limited by guarantee (company number 07135273 and registered charity number 1134586). Previously, the Charity operated as the Fair Trials Abroad Trust (charity number 1079079). The Charity is governed by its Memorandum and Articles of Association which were signed on 25 January 2010. The Memorandum and Articles of Association of the Charity were amended on 21 July 2020 to revise the Charity's objects.
In recognition of the Charity's increasing work with the institutions of the European Union, the Charity opened an office in Brussels in April 2014 and, in May 2014, founded Fair Trials Europe, a registered public foundation in Belgium (registered number 0552.688.677: 12A, Avenue Brugmann, 7th Floor, Saint-Gilles, Brussels, Belgium, 1060). Also, consistent with the Charity's strategy of expanding the global reach of its work, Fair Trials Americas was incorporated in Washington D.C. on 12 April 2017. Fair Trials Americas (Address 1100 13th NW, Suite 800, Washington DC, 20005, USA) was granted 501(c)3 status in February 2018. The financing arrangements currently in place and the power to cast the majority of votes at meetings of its board are the determining factors that Fair Trials Europe be treated as a controlled subsidiary of the Charity (see note 8). The financing arrangements currently in place, the role of the global CEO, control over key operating and financial decisions and the concurrent purposes of the charities are the determining factors that Fair Trials Americas be treated as a controlled subsidiary of the Charity (see note 8).
Fair Trials Europe, Fair Trials Americas and the Charity operate under the name "Fair Trials". As of November 2024, operations for Fair Trials International and Fair Trials Americas ceased and Fair Trials Europe continued as an independent entity.
Trustees
The directors of the Charity are its trustees for the purposes of charity law (the "Trustees"). The Trustees who have served during this year and since the year end are set out in the legal and administrative information at the front of the Report and Accounts.
Three of the Trustees are also members of the Board of Directors ("Administrateurs") of Fair Trials Europe and three trustees are members of the board of directors for Fair Trials Americas. The Charity's Chief Executive is also a non-voting director on the Boards of Fair Trials Europe and Fair Trials Americas.
2
Members’ Liability
Each member of the charitable company undertakes to contribute to the assets of the charitable company in the event of it being wound up while they are a member, or within one year after they cease to be a member, such amount as may be required, not exceeding £1, for the debts and liabilities contracted before they ceased to be a member.
Trustees’ Indemnities Public Benefit
Trustees benefit from indemnity insurance to cover the liability of the Trustees which by virtue of any rule of law would otherwise attach to them in respect of any negligence, default or breach of trust or breach of duty of which they may be guilty in relation to the Charity. This is covered within the overall cost of the Risk Protection Insurance. The trustees decided that this cover met the risk management requirements.
Public Benefit
In setting our objective and planning out activities the trustees have carefully considered the Charity Commission’s general guidance on public benefits.
Selection and appointment of Trustees
Trustees regularly review the composition of the Board and, when vacancies arise, identify the skills needed to complement the Trustees' existing skills. Potential new Trustees are agreed by existing Trustees and are appointed by a resolution of the Board of Trustees. The Trustees appoint the Chief Executive who is responsible for leading Fair Trials and for working with the Trustees to develop and implement Fair Trials' strategic goals.
Induction and training of Trustees
Prior to their appointment, new Trustees meet with the Chair and Chief Executive to discuss the role and are provided with key documentation relating to Fair Trials, including the Trustee role description. Following their appointment, new Trustees are briefed by the Chief Executive on the work of Fair Trials and provided with materials, including strategy documents. Additional training needs for Trustees are kept under review to ensure the Board has the necessary knowledge, skills and experience.
Risk management
The organizational risk register is regularly reviewed by the Chief Executive, Finance Director and wider staff team. The Finance Subcommittee reviews the risk register as part of the Trustees' risk management strategy to regularly review the principal risks and uncertainties that Fair Trials faces and ensure that measures to eliminate, reduce or mitigate risks are in places, including as a result of strengthened of policies, systems and procedures.
The Trustees have assessed the major risks, in particular those relating to operations and finance, and are satisfied that the measures that in place to moderate exposure to risks are sufficient. The principal risks identified are as follows:
-
Failure to raise sufficient funds to cover costs, resulting in revenue and reserves failing to keep pace with Fair Trials’ operational needs;
-
Reduced staff team and uncertainty undermines organizational ability to deliver high quality work;
-
• Reputation is negatively impacted by recent organizational uncertainty
3
The Trustees' response to these is reflected in part in the financial statements for the year. This includes:
-
Engaging with critical funders to seek continued support for Fair Trials, with only partial funding achieved during the year;
-
Appointment of a highly-qualified specialist Interim CEO to lead the change management process of restructuring and rebuilding;
-
Continued careful management of broader critical stakeholder relations.
Despite these efforts, the lack of additional funding triggered the decision to wind up the organization. The Trustees ensured that the closure was conducted responsibly and in alignment with the charity’s governance framework.
Related parties
The Trustees consider the Chief Executive Officer and Finance Director to have been the key management personnel of Fair Trials during the year, in charge of directing and controlling, running and operating Fair Trials on a day to day basis. None of the Trustees receive any remuneration or other benefits from their work for Fair Trials. Any conflicts of interest, including those resulting from connections between Trustees and key management and third parties, must be disclosed at the Trustees' meeting and are then noted in a register of conflicts. All potential conflicts were reviewed by the Trustees and considered to have no practical effect. Related party transactions are referred to in note 16.
Pay policy
The pay of all staff is reviewed annually, with changes made outside that process when warranted. Salaries are reviewed and approved by a sub-committee of Trustees. Management provide recommendations for salary increases and updates to banding levels, where available, for subcommittee review. For key management personnel, salaries are reviewed annually with recommendations made by the relevant line manager and, in the case of the Chief Executive, by the Chair of Trustees. Reviews include evaluations of professional performance and Fair Trials' institutional performance in meeting its strategic and financial objectives. The last cost-of-living annual salary review for all staff was completed in April 2024.
Vision, mission, and strategic aims
Fair Trials envisions a world where governments use the power of the criminal process with utmost restraint, humanity, fairness, equality, and respect for human rights and dignity. Fair Trials’ mission is to serve as an international criminal justice watchdog, working to monitor, challenge, and inform systemic reform in criminal processes. Through robust evidence-based research, Fair Trials supports coalitions to promote and guarantee the enjoyment of fundamental human rights at all stages of the criminal process.
In 2022, the Trustees approved a revised strategic plan that articulated 20 core principles, including 10 that address the essential values of a fair criminal justice system, 6 that speak to procedural fairness, and 4 that focus on circumscribing the scope of state criminal enforcement.
Fair Trials articulated five key advocacy areas as follows:
1. Promote procedural fairness and transparency
- Access to counsel at the commencement of custody;
4
-
access to resources necessary to conduct an effective and technical defence;
-
the right to discovery;
-
an opportunity to investigate and access expert services;
-
compliance with international and national standards of fairness, human rights, and due process;
-
protection of the opportunity to exclude unlawfully obtained evidence;
-
compliance with procedural safeguards, such as the right to confront and cross-examine witnesses, the right to compulsory process, the right to a speedy trial before a fair and impartial trier of fact, the right to appeal, and the right to post-appeal collateral relief for injustice or wrongful conviction;
-
limitations on coercive waivers;
-
limitations on fast track procedures.
Transparency compels the compilation, analysis, and publication of criminal justice statistical data.
2. Oppose overcriminalisation
-
Limitations on the prosecution of minor offences;
-
proactive and diversionary approaches to those suffering from mental health or neurodivergent conditions, substance abuse or other pathologies that are more appropriately redressed through treatment;
3. Oppose overincarceration
-
Addressing pretrial detention;
-
alternatives to incarceration;
-
pilot projects to advance restorative justice models;
-
• second look legislation.
4. Identify and work to eliminate systemic racism, implicit bias, and disparate treatment based upon discrimination
5. Rein in government overreach through the misuse of the police power and privatisation of criminal justice
-
monitor and redress misuse of wanted alerts;
-
identify and restrain the misuse of Artificial Intelligence {Al), algorithmic tools and technology that is not human rights compliant for security and justice tasks.
5
Organizational highlights:
Rule of Law and Due Process
Fair Trials has successfully advanced the FLIGHTRISK project in Europe in collaboration with several European partners. The network has conducted extensive and detailed domestic and regional research. In 2024, this project resulted in the publication of five national reports, three regional reports, and a comprehensive comparative report. The analysis includes an in-depth review of regional judicial standards.
Fair Trials often participates in conferences that aim at disseminating international standards and promoting best practices, for example, at the International Congress on Artificial Intelligence, Law, and Democracy in Mexico City and at the Data Protection Day in Brussels.
Fair Trials continues to disseminate the Méndez Principles in Latin America and East Africa to promote the effective gathering of information for criminal proceedings, including through research and training. The work in East Africa, particularly in Kenya, is supported by pro bono engagement from UK law firms and universities.
Fair Trials continues to work with the legal firm Freshfields on the creation of a Global Fair Trials Index to review fair trial standards worldwide, develop indicators, and work on case studies covering pre-trial detention, plea bargaining, and artificial intelligence. The development of this ambitious project and associated open-source global index is expected to take several years.
Networks
Fair Trials continues to coordinate and lead the Legal Expert Advisory Panel (LEAP), a group of legal professionals with diverse backgrounds and experiences, working in multiple jurisdictions across the European Union. Fair Trials works with the network to identify critical legal issues to be highlighted and researched and where appropriate to develop advocacy positions and materials to support the continued reform of criminal justice systems across the European Union.
Key Performance Indicators
Fair Trials' reduced level of activity is reflected in the financial statements. Incoming resources decreased from £1,512,977 in 2022/23 to £908,534 this year, a decrease of 40%. Fair Trials reports income of £431,092 {2022/22: £713,126} for specific activities which is shown as restricted funds (see note 13). Fair Trials reports £477,442 (2022/23: £799,851} of unrestricted income.
The majority of Fair Trials' restricted income comes from statutory or foundation sources, including governmental funders (£188,241 in 2023/24: £328,921 in 2022/23}, mainly the European Commission; and the Koch Foundation {£54,092 in 2023/24: £86,533 in 2022/23}. Fair Trials also received support from the Arnold Foundation, Open Society Foundation, Mozilla Foundation and Freshfields towards specific project activities.
In 2023/24 Fair Trials received large core grants from the Oak Foundation (£275,000 in 2023/24: £275,000 in 2022/23), and Sigrid Rausing Trust (£150,000 in 2023/24: £150,000 in 2022/23) to support its core activities. The majority of the remainder of Fair Trials' unrestricted income comes from other trust grants, donations from law firms and individual donations. Further details can be found in note 2.
The Trustees are very grateful to all of Fair Trials' donors for their ongoing support and confidence in Fair Trials' work.
6
Expenditure
With the significant reduction in charitable activity, there was a corresponding decrease in expenditure. Expenditure decreased from £1,522,143 in 2022/23 to £985,743 this year, a decrease of 35%. Fair Trials therefore made a deficit in the period of £77,209 (2022/23 deficit £39,166) which has been deducted from its reserves. At 31 March 2024, Fair Trials' fund balance stood at £237,215 (2022/23: £314,424).
The reduction in costs relate to lower staff associated with a reduction in activities globally. Expenditure on charitable activities for Fair Trials America decreased from £452,299 in 2022/23 to £179,950, a decrease of 60%, due to closing off the activities taking place around areas such as the legal right to counsel, plea bargaining and other key global advocacy topics
The Charity's own charitable expenditure decreased from £345,453 in 2022/23 to £321,860, a decrease of 7% as activities gradually reduced in the United Kingdom.
Fair Trials Europe
During the year, as well as direct grants to Fair Trials Europe, the Charity supplied a grant of €95,000 to support Fair Trials Europe in meeting Fair Trials' charitable aims. These intra-group transactions are included in the Charity's financial statements as a net creditor but have been eliminated on consolidation. Details of these amounts can be found in notes 8 and 12. The majority of Fair Trials Europe's income in the year came from EU grants, mainly from The European Commission, together with the grant from the Charity.
Fair Trials Americas
In the financial year 2023/24 the Charity supplied grants of £53,051 to support Fair Trials Americas in meeting Fair Trials' charitable aims. These intra-group transactions are included in the Charity's financial statements as a net creditor but have been eliminated on consolidation. Details of these amounts can be found in notes 8 and 12.
Reserves Policy
The Trustees examined the requirement to maintain free reserves and concluded that Fair Trials globally should seek to maintain unrestricted reserves equivalent to approximately three months' core operating expenditure. This reserve level is intended to include permanent staff and office costs for Fair Trials but exclude discrete project costs. For the year ahead, three months' core expenditure was budgeted at approximately £160,000, setting the target reserves level at this amount.
As organizational costs decreased throughout the year, the required reserves level also decreased proportionately. This approach was intended to ensure that sufficient reserves would be available to cover all closure costs for Fair Trials International in November 2024.
However, following the year-end, the Charity received a legal claim from a former employee whose employment ended after the reporting period. The Trustees are seeking legal advice to assess the validity and potential impact of the claim and will address any implications in the subsequent reporting period.
Following the closure of the charity, available remaining reserves will be transferred to Fair Trials Europe to support the continuity of operations and advance the organization's charitable objectives through Fair Trials Europe.
7
Fundraising
During the year, fundraising activities were primarily conducted by the Chief Executive. Unlike previous years, there were no dedicated in-house staff for fundraising. The Chief Executive played a pivotal role in managing relationships with governmental funders, trusts, and foundations, as well as exploring opportunities to secure resources to permit the Charity to continue its operations. fn.
The majority of the Charity's funds come from institutional funders, including governmental organizations, trusts, and law firms. Interactions with funders are handled professionally, often through direct relationships, third-party introductions, or publicly available sources.
Donations from private individuals remained a small but valued part of the Charity's income. These donations were generally unsolicited and received from individuals who became aware of the Charity's work. Fundraising requests were limited to individuals on Fair Trials' mailing list, all of whom had consented under GDPR and Fundraising Regulator guidelines. The Charity adhered to all relevant fundraising standards, including responsible management of donor relationships.
During the financial year, the Charity also engaged an external contractor to support specific fundraising activities. This approach was adopted to maintain the organization's ability to seek and secure funding while managing limited internal resources effectively.
No complaints were received regarding fundraising activities during the financial year. As part of the winding-up process, all fundraising activities were responsibly concluded.
Trustees' responsibilities statement
The Trustees (who are also directors of Fair Trials International for the purposes of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the Charity and the group and of their incoming resources and application of resources, including the income and expenditure, of the Charity and the group for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities Statement of Recommended Practice (SORP) (FRS102);
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on a basis of other than going concern, reflecting the decision to wind up operations.
The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
There was no statutory audit conducted for the financial year, as the Trustees assessed that the
8
Charity did n¢X m••t the statutory thresholds requiring an audiL In 80 far a8 the Trustees are aware: there 1$ no rol•vant infomiation of the tharitabl• rkimpanvs aGcount8nt is unaware; and the Trustees have taken 4K stops that they ought to h•ve taken to make themsel1 aware of any relevanl flnanaal Infomatson and to eFt8blish that the financial ststements h•v• btsan prepared to the boal of thelr knuwleuge ¥nU undornigndlng- The Tru•lee8 •re responsible for the malnlen8nc* and Intsqrlty of thé corpor•t• And financial infom)•tiDn includ•d on th8 Charity'5 web8rt•. L•gi•lation in the United Kingdom govèrning thp preparation and di18amin8lion of financial •t•tem•nl• m•y differ from legls14Ion in olher lurkqdicllon$. Th1$ report of the Board ol Truslee$ has been pr8p8r•d taking •dv8nt•g• ol th• imall companies •xemption of lection 415A of th• Compani•• Act 2006. Slne• th• Ch•nty quallfies ao 4ffl411 un¢•f 383, the 8tratsaic report reqUIj of medium and larG8 compiniès und•r Th• C>•n kt 2008 (Str•t•gi¢ R•port •nd Dir•ctr)fs Report) 1189ul•ts'ons 2013 rs not roqulred. Thii r•port wab approv8d and •uthoriBed for l••ue by the 8a8rO of Trustees on V January 2025 and •igned on its behBV by.. Eric Kobdr
FAIR TRIALS INTERNATIONAL
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES
(incorporating Income and Expenditure Account & Statement of Total Realised Gains and Losses) For the year ended 31 March 2024
| Unrestricted Funds Note 2024 £ INCOME FROM: Donations and legacies 2 477,442 Charitable activities: 4 Fair Trials International - Fair Trials Europe - Fair Trials Americas - TOTAL INCOMING RESOURCES 477,442 EXPENDITURE ON: Raising funds 33,620 Charitable activities: Fair Trials International 196,075 Fair Trials Europe 211,215 Fair Trials Americas 113,741 TOTAL EXPENDITURE 5 554,651 (77,209) RECONCILIATION OF FUNDS Total funds brought forward 13 314,424 TOTAL FUNDS CARRIED FORWARD 13 237,215 NET INCOME |
Unrestricted Funds Note 2024 £ INCOME FROM: Donations and legacies 2 477,442 Charitable activities: 4 Fair Trials International - Fair Trials Europe - Fair Trials Americas - TOTAL INCOMING RESOURCES 477,442 EXPENDITURE ON: Raising funds 33,620 Charitable activities: Fair Trials International 196,075 Fair Trials Europe 211,215 Fair Trials Americas 113,741 TOTAL EXPENDITURE 5 554,651 (77,209) RECONCILIATION OF FUNDS Total funds brought forward 13 314,424 TOTAL FUNDS CARRIED FORWARD 13 237,215 NET INCOME |
Restricted Funds 2024 £ - 125,785 240,098 65,209 |
Total Funds 2024 £ 477,442 125,785 240,098 65,209 |
Total Funds 2023 £ 799,851 127,221 339,059 246,846 |
|---|---|---|---|---|
| 477,442 | 431,092 | 908,534 | 1,512,977 | |
| 33,620 196,075 211,215 113,741 |
- 125,785 240,098 65,209 |
33,620 321,860 451,313 178,950 |
198,076 345,453 556,315 452,299 |
|
| 431,092 | 985,743 | 1,552,143 | ||
| - - |
(77,209) 314,424 |
(39,166) 353,590 |
||
| - | 237,215 | 314,424 |
All income and expenditure derive from continuing activities
The annexed notes form part of these financial statements
10
FAIR TRIALS INTERNATIONAL (company limlted by guarantee BALANCE SHEETS (COMPANY NUMBER: 07135273) As at 31 March 2024 Nots• Charity 2024 Group 2024 Chatlly 2023 Gmtsp 2023 FIXED ASSETS Tangible assets 10 3,278 3,278 5.174 5,174 7,391 7,391 12.276 12,276 CURRENT ASSErs Debtors Cash at bank and In hand 28,098 257,968 39,228 433,777 31,405 727,524 86, 638 1,191.052 286,056 473,006 758, 929 1,277,690 CREDITORS: amounts falling due wlthln ono yoar 12 (127,499) (240,964) (569,549) (975,542) NET CURRENT ASSET8 58,557 232,041 189.380 302, 148 NET ASSETS 161,836 237,215 196.771 314,424 FUNDS Unrestricted funds: Sub8ldiary companles G8neral fund 13 13 75,380 61.835 237,215 161,835 161,835 117,653 196, 771 314.424 196, 771 196, 771 TOTAL FUNDS 101,835 237,215 196,771 314,424 The CharFty's tlnancial statements havé been prepared in accordance the provision$ appllcable to MpanIeS subject to the small companieB regimg. These financial statements re approved and authorlsed for Islue by ihe Board ol Tru8tee8 on 9th January 2025 and 51gnea on tmeir behatt by.. The annexed notes form part of these financial statemènts 16
FAIR TRIALS INTERNATIONAL (company limited by guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 March 2024
| Notes Cash flow from operating activities 15 Net cash flow from operating activities Cash flow from investing activities Payments to acquire tangible fixed assets 10 Net cash flow from investing activities Net cash flow from financing activities Net increase / (decrease) in cash and cash equivalents Cash and cash equivalents at 1st April CASH AND CASH EQUIVALENTS AT 31 MARCH Cash and cash equivalents consists of: Cash at bank and in hand CASH AND CASH EQUIVALENTS AT 31 MARCH |
Charity 2024 £ (469,566) (469,566) - - - (469,566) 727,524 257,958 257,958 257,958 |
Group 2024 £ (757,275) (757,275) - - - (757,275) 1,191,052 433,777 433,777 433,777 |
Charity 2023 £ 407,824 407,824 - - - 407,824 319,700 727,524 727,524 727,524 |
Group 2023 £ 503,691 |
|---|---|---|---|---|
| 503,691 | ||||
| - | ||||
| - | ||||
| - | ||||
| 503,691 687,361 |
||||
| 1,191,052 | ||||
| 1,191,052 | ||||
| 1,191,052 |
The Charity and the Group do not have net debt as at 31 March 2024 (2022/23 - Nil)
17
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
1. Summary of significant accounting principles
General information and basis of preparation
Fair Trials International ("the Charity") is a private company limited by guarantee registered in England and Wales. The members of the company are its trustees. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per Trustee of the Charity. The address of the registered office is given in the charity information on page 1 of these financial statements. The nature of the Charity's operations and principal activities are detailed on the Trustee's Annual Report.
The Charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with 'Accounting and Reporting by Charities: Statement of Recommended Practice' applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Practice as it applies from 1 January 2015.
The financial statements cover the period up to 31 March 2024, which precedes the Charity’s cessation of operations in November 2024. The accounts have been prepared on a basis of other than going concern due to the decision to wind up operations and close the Charity. Assets have been valued at their realizable amounts, and all liabilities have been fully accounted for.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.
Basis of other than going concern
The financial statements have been prepared on a basis of other than going concern following the Trustees' decision to wind up operations by 30 November 2024. Therefore, the going concern assumption is not applied. The Trustees have assessed the Charity’s financial position and concluded that it has adequate resources to meet all obligations during the closure process. Assets have been valued at their realizable amounts, and known liabilities have been fully recognized as of the reporting date.
Group financial statements
These financial statements consolidate the results of the Charity and its wholly-controlled subsidiaries, Fair Trials Europe and Fair Trials Americas, on a line by line basis. Fair Trials International and Fair Trial Americas ceased operations as part of the winding-up process in November 2024, while Fair Trials Europe continues as an independent entity with separate governance and funding arrangements. A separate Statement of Financial Activities for the Charity itself is not presented because the Charity has taken advantage of the exemptions afforded by section 408 of the Companies Act 2006.
The financial statements are prepared in sterling which is the functional currency of the Charity, and rounded to the nearest pound.
Fund accounting
Unrestricted funds are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.
10
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
Income recognition
All incoming resources are included in the Statement of Financial Activities (SoFA) when the Charity is legally entitled to the income after any performance conditions have been met, the amount can be measured reliably and it is probable that the income will be received.
For donations to be recognised the Charity will have been notified of the amounts and the settlement date in writing. If there are conditions attached to the donation and this requires a level of performance before entitlement can be obtained then income is deferred until those conditions are fully met if the fulfilment of those conditions is within the control of the Charity and it is probable that they will be fulfilled.
Donated facilities and donated professional services are recognised in income at their fair value when their economic benefit is probable, it can be measured reliably and the Charity has control over the item. Fair value is determined on the basis of the value of the gift to the Charity. For example the amount the Charity would be willing to pay for such facilities and services. A corresponding amount is recognised in expenditure.
No amount is included in the financial statements for volunteer time in line with the SORP (FRS 102). Further detail is given in the Trustees' Annual Report.
Income related to the wind-up process, including final grant payments and donations, is recognised in accordance with the specific terms of the agreements. This ensures that all income is appropriately matched to the reporting period up to 31 March 2024.
Expenditure recognition
All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Expenditure is recognised where there is a legal or constructive obligation to make payments to third parties, it is probable that the settlement will be required and the amount of the obligation can be measured reliably. It is categorised under the following headings:
-
Costs of raising funds includes staff time and associated support costs of fundraising activities; - Expenditure on charitable activities includes the direct meetings, communications, travel and staff costs of our activities and associated support costs.
-
Other expenditure represents those items not falling into the categories above.
-
Termination benefits, including redundancy costs, are recognised when the charity has the obligation to pay the benefits and they can be reliably measured.
Irrecoverable VAT is charged as an expense against the activity for which the expenditure arose.
Termination benefits and wind-up costs, while accounted for when the Charity has a binding obligation to pay, have primarily been incurred in the cessation accounts following 31 March 2024. These costs have not been recognised in these financial statements but have been disclosed as part of the Post-Balance Sheet Events note to ensure transparency and compliance with accounting principles.
11
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
Support costs allocation
Support costs are those that assist the work of the Charity but do not directly represent charitable activities and include office costs, governance costs and administrative payroll costs. They are incurred directly in support of expenditure on the objects of the Charity and include project management. Where support costs cannot be directly attributed to particular headings they have been allocated to cost of raising funds and expenditure on charitable activities based on the proportion of direct staff time attributable to each category.
Fundraising costs are those incurred in seeking voluntary contributions.
The analysis of these costs is included in notes 5 and 6.
Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.
Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a straight-line basis over its expected useful life as follows:
Fixtures, fittings & equipment 25% per annum Office improvements 20% per annum
Debtors and creditors receivable / payable within one year
Debtors are recognised when the Charity is legally entitled to the income after any performance conditions have been met, the amount can be measured reliably and it is probable that the income will be received.
Creditors are recognised when the Charity has a present legal or constructive obligation resulting from a past event to make a payment to a third party, it is probable that settlement will be required and the amount due to settle the obligation can be measured or estimated reliably.
Financial Instruments
The Charity only holds basic Financial Instruments. The financial assets and financial liabilities of the Charity are as follows:
Debtors – trade and other debtors (including accrued income) are basic financial instruments and are debt instruments measured at amortised cost as detailed in Note 11. Prepayments are not financial instruments. Cash at bank – is classified as a basic financial instrument and is measured at face value. Liabilities – trade creditors, accruals and other creditors will be classified as financial instruments, and are measured at amortised cost as detailed in Note 12. Deferred income is not deemed to be a financial liability, as the cash settlement has already taken place and there is simply an obligation to deliver charitable services rather than cash or another financial instrument. Funds held for partners and funds held for Fair Trials Europe are not financial instruments.
Concessionary loans
Concessionary loans include loans between the parent Charity, Fair Trials International, and the subsidiary Foundation, Fair Trials Europe which are interest free and made to advance charitable purposes. The loan is repayable on demand within one year and is measured at cost, less impairment.
12
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
Operating leases
Rentals payable under operating leases are charged to the statement of financial activities on a straight line basis over the period of the lease.
Foreign Currencies
Transactions in foreign currencies are recorded at the average rate ruling at the date of the transaction. Monetary and non-monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the balance sheet date. All differences are taken to the statement of financial activities.
Judgements and key sources of estimation uncertainty
The following judgements (apart from those involving estimates) have been made in the process of applying the above accounting policies that have had the most significant effect on amounts recognised in the financial statements
-
Allocation of support costs
-
Entitlement to income for certain grant funded projects in progress
-
Depreciation of tangible fixed assets and their useful economic lives;
-
Useful economic lives of assets
-
Recognition and treatment of wind-up costs, including redundancy payments and contractual termination costs, which are disclosed as post-balance sheet events due to their occurrence after the reporting date.
Given the Charity’s closure, the financial statements have been prepared on a basis of other than going concern. The Trustees have exercised judgement in valuing assets at their realizable amounts and assessing known liabilities as of the reporting date.
Employee benefits
When employees have provided a service to the Charity, salaries and other short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service. This includes the cost of annual leave which employees were entitled to but which was not taken during the reporting year.
The Charity operates a defined contribution pension plan for the benefit of its employees. Contributions are expensed as they become payable.
The costs and liabilities associated with employee benefits are allocated to activities and restricted and unrestricted funds based on days and percentage of time worked on specific projects.
13
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
2. INCOME FROM DONATIONS AND LEGACIES
| Trusts and Foundations Law Firms Donated services Individual donors Bank Interest Trusts and Foundations Law Firms Donated services Individual donors UK Government - CJRS |
Unrestricted Funds 2024 £ 447,000 24,000 - 5,922 520 477,442 2023 £ 767,870 26,500 - 5,436 45 799,851 |
Restricted Funds 2024 £ - - - - - - 2023 £ - - - - - - |
Total Funds 2024 £ 447,000 24,000 - 5,922 520 |
|---|---|---|---|
| 477,442 | |||
| 2023 £ 767,870 26,500 - 5,436 45 |
|||
| 799,851 |
Income from donations and legacies was £477,442 (2022/23: £799,851) of which £477,442 was unrestricted (2022/23: £799,851) and none was restricted (2022/23: £Nil).
Details of donated services are given in note 3.
| Bromley Trust Colucci Foundation Evan Cornish Foundation Allen & Overy Foundation Ptarmigan Trust Oak Foundation Open Society Foundations The 3 Ts Charitable Trust Other trusts & foundations Sigrid Rausing Trust Souter Charitable Trust Grants from trusts and foundations : |
2024 Unrestricted £ - - - 5,000 2,000 275,000 - 150,000 - 15,000 447,000 |
2024 Restricted £ - - - - - - - - - - - - |
2023 Unrestricted £ 15,000 5,389 12,500 10,000 - 275,000 276,480 150,000 3,000 15,000 7,162 769,531 |
2023 Restricted £ - - - - - - - - - - - |
|---|---|---|---|---|
| - |
14
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Donations from law firms: Freshfields BCL Solicitors Garden Court Chambers Ltd Stafford Young Jones |
2024 Unrestricted £ 22,000 2,000 - - 24,000 |
2024 Restricted £ - - - - - |
2023 Unrestricted £ 20,000 - 5,000 1,500 26,500 |
2023 Restricted £ - - - - |
|---|---|---|---|---|
| - |
The Charity is very grateful to all those who have donated this year including Freshfields, the 3 T's Charitable Trust, the Ptarmigan Trust, Allen & Overy Foundation and all those listed above.
3. DONATED SERVICES
The charity did not receive any donated services during the financial year ended 31 March 2024, nor in the prior year ended 31 March 2023.
15
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
4. INCOME FROM CHARITABLE ACTIVITIES
| EU grants Arnold Foundation Koch Foundation Open Society Foundations Freshfields Role UK Stitching Digital Freedom Fund European AI Fund Mozilla Foundation EU grants Arnold Foundation Koch Foundation Open Society Foundations Freshfields Mary Jane & Associates Barrow Cadbury Role UK Stitching Digital Freedom Fund European AI Fund Irish Embassy - Mexico Mozilla Foundation UKRI Porticus |
Unrestricted Funds 2024 £ - - - - - - - - - - 2023 £ - - - - - - - - - - - - - - - |
Restricted Funds 2024 £ 188,241 2,149 54,092 109,546 2,795 13 13,430 51,858 8,968 431,092 2023 £ 328,921 124,004 86,534 48,267 26,276 24,873 21,294 16,182 13,362 10,138 8,326 3,109 1,140 701 713,127 |
Total Funds 2024 £ 188,241 2,149 54,092 109,546 2,795 13 13,430 51,858 8,968 |
|---|---|---|---|
| 431,092 | |||
| 2023 £ 328,921 124,004 86,534 48,267 26,276 24,873 21,294 16,182 13,362 10,138 8,326 3,109 1,140 701 |
|||
| 713,127 |
Within EU grants £188,241 (2022/23: £328,921) of government grants were received from the European Commission. There were no contingencies or unfulfilled conditions relating to this funding.
16
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
5. RESOURCES EXPENDED
| Fair Trials International Fair Trials Americas Fair Trials Europe Costs of raising funds Support costs Fair Trials International Fair Trials Americas Fair Trials Europe Costs of raising funds Support costs Total charitable expenditure Total charitable expenditure |
Direct Staff Costs 2024 £ 63,237 127,149 203,936 394,322 23,866 178,998 597,186 2023 £ 225,051 315,874 339,470 880,395 150,908 195,854 1,227,157 |
Other activites under-taken directly 2024 £ 97,182 17,458 65,319 179,959 - 208,598 388,557 2023 £ 22,411 58,691 38,391 119,493 - 205,493 324,986 |
Support costs 2024 £ 161,441 34,343 182,058 377,842 9,754 (387,596) - 2023 £ 97,991 77,734 178,454 354,179 47,168 (401,347) - |
Total 2024 £ 321,860 178,950 451,313 |
|---|---|---|---|---|
| 952,123 33,620 - |
||||
| 985,743 | ||||
| 2023 £ 345,453 452,299 556,315 |
||||
| 1,354,067 198,076 - |
||||
| 1,552,143 |
Resources expended include:
| Auditors’ remuneration: Charity Subsidiary Depreciation on owned assets |
2024 £ - 4,321 6,979 11,300 |
2023 £ 21,535 3,352 8,946 |
|---|---|---|
| 33,833 |
Expenditure on charitable activities was £952,123 (2022/23: £1,354,067), of which £431,092 was restricted (2022/23: £713,126) and £521,031 was unrestricted (2022/23: £640,941). The costs of raising funds was £33,620 (2022/23: £198,076) all of which was unrestricted (2022/23 all unrestricted).
17
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
6. SUPPORT AND GOVERNANCE COSTS
| Support staff costs Depreciation Audit fees Charity Subsidiary Other governance costs Support staff costs Depreciation Audit fees Charity Subsidiary Other governance costs 7. STAFF COSTS AND NUMBERS Wages and salaries Social security costs Pension costs Other staff costs Office, administration and other support costs Office, administration and other support costs |
General Support 2024 £ 173,381 6,979 197,298 - - - 377,658 2023 £ 188,729 8,947 171,659 - - - 369,335 |
Governance 2024 £ 5,617 - - - 4,321 - 9,938 2023 £ 7,125 - - 21,535 3,352 - 32,012 2024 £ 524,471 58,601 9,171 4,943 597,186 |
Total 2024 £ 178,998 6,979 197,298 - 4,321 - |
|---|---|---|---|
| 387,596 | |||
| 2023 £ 195,854 8,947 171,659 21,535 3,352 - |
|||
| 401,347 | |||
| 2023 £ 1,064,829 124,735 16,231 21,361 |
|||
| 1,227,156 |
Staff costs for 2023/24 include termination benefits totalling £Nil (2022/23: £Nil). Payments in lieu of notice and redundancy were £Nil (2022/23: £Nil). Total termination benefits include wages and salaries of £Nil (2022/23 : £Nil) and social security costs of £Nil (2022/23 £Nil).
Termination benefits and redundancy costs arising from the decision to wind up the organisation, made in September 2024, will be fully accounted for in the subsequent reporting period ending November 2024. These costs, including any payments in lieu of notice and redundancy payments, are disclosed under Note 17. Salaries paid to staff during their notice periods worked within the operational period are included within operational expenses for the year ended 31 March 2024.
18
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
The full time equivalent number of group employees during the year was as follows.
| Costs of raising funds Charitable activities: Fair Trials International Charitable activities: Fair Trials Europe Charitable activities: Fair Trials Americas Support |
2024 Number 0.2 2.5 2.4 0.5 2.4 8.0 |
2023 Number 2.3 4.3 6.1 2.6 2.9 |
|---|---|---|
| 18.2 |
The average monthly number of group employees during the year was as follows:
| Costs of raising funds Charitable activities: Fair Trials International Charitable activities: Fair Trials Europe Charitable activities: Fair Trials Americas Support The employment benefits of higher paid staff were as follows: Number of employees who received £60,001 - £70,000: Number of employees who received £70,001 - £80,000: Number of employees who received £80,001 - £90,000: Number of employees who received £90,000 - £100,000: Number of employees who received £100,000 - £110,000: Number of employees who received £110,000 - £120,000: Number of employees who received £120,000 - £130,000: |
2024 Number 0.2 2.5 2.4 0.5 2.4 8.0 2024 1 - - 1 - - - |
2023 Number 2.5 4.4 6.1 2.3 2.9 |
|---|---|---|
| 18.2 | ||
| 2023 1 2 1 - - - 1 |
8. SUBSIDIARY AND RELATED FOUNDATIONS
In May 2014 the Charity founded Fair Trials Europe, a public foundation registered in Belgium. Fair Trials Europe has an independent Board of Directors a majority of which are Trustees of the Charity. Financing arrangements and the power to cast the majority of votes at meetings of the Board are the determining factors that it be treated as a controlled subsidiary of the Charity and its results have been consolidated in these financial statements.
Fair Trials Europe coordinates Fair Trials' European Network (the Legal Experts Advisory Panel 'LEAP') and other European projects. Relevant financial information is as follows:
| Income Expenditure |
2024 £ 322,374 (324,202) (1,828) |
2023 £ 442,677 (436,065) |
|---|---|---|
| 6,612 |
19
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Fixed assets Current assets Liabilities General funds |
1,485 259,702 (196,245) 64,942 64,942 |
4,205 461,651 (399,086) |
|---|---|---|
| 66,770 | ||
| 66,770 |
The Charity provided grants to Fair Trials Europe during the year totalling £81,271 (2022/23: £105,687). At the year end there was a balance of £27,835 owing by the Charity to Fair Trials Europe (2022/23: £184,953 owing by the Charity to Fair Trials Europe). The outstanding balance was settled during the period ended November 2024..
In April 2017 the Charity founded Fair Trials Americas, a public charity registered in the USA in the District of Columbia. The charity's Internal Revenue Code Section 501 (c) 3 status was approved in February 2018. Fair Trials Americas has an independent Board of Directors that includes certain Trustees of the Charity. The corporation has no members and is managed by its board of directors. For the year ended 31 March 2024, a single global CEO, financing arrangements, control over key operating and financial decisions and the concurrent purposes of the charities, are the determining factors that it be treated as a controlled subsidiary of the Charity and its results have been consolidated in these financial statements. Relevant financial information is as follows:
| Income Expenditure Fixed assets Current assets Liabilities General funds |
2024 £ 120,467 (160,911) (40,444) 410 13,676 (3,648) 10,438 10,438 |
2023 £ 539,894 (516,455) |
|---|---|---|
| 23,439 | ||
| 680 433,572 (383,370) |
||
| 50,882 | ||
| 50,882 |
The Charity provided grants to Fair Trials Americas during the year totalling £56,241 (2022/23: £194,906). At the year end there was no balance owing to the Charity by Fair Trials Americas (2022/23: £147,376).
The income of the Charity in the year was £601,397 (2022/23: £919,997) and its expenditure including grant giving was £636,333 (2022/23: £989,216). A deficit of £34,936, was made in the year (2022/23: deficit £69,219)
20
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
9. TRUSTEES' AND KEY MANAGEMENT PERSONNEL REMUNERATION AND EXPENSES
The Charity's trustees neither received nor waived any remuneration from Fair Trials during the year (2022/23: £Nil)
The total amount of employee benefits received by key management personnel is £162,348 (2022/23: £219,200). The charity considers its key management personnel comprise the Trustees, Chief Executive and the Finance Director.
There was no interest-free travel loan in the 2023/24 financial year for key management personnel (2022/23: £Nil).
Reimbursment of expenses to trustees or paid on their behalf in the year totalled Nil (2022/23: £Nil).
10. TANGIBLE FIXED ASSETS
| Group | Fixtures, fittings and equipment |
|---|---|
| £ | |
| Cost | |
| At 1 April 2023 | 91,918 |
| Additions | - |
| Disposals | - |
| Foreign exchange | (1,014) |
| At 31 March 2024 | 90,904 |
| Depreciation | |
| At 1 April 2023 | 79,642 |
| Charge for the period | 6,979 |
| On disposals | - |
| Foreign exchange | (891) |
| At 31 March 2024 | 85,730 |
| Net book value | |
| At 31 March 2024 | 5,174 |
| At 31 March 2023 | 12,276 |
| Charity | Fixtures, fittings and equipment |
| £ | |
| Cost | |
| At 1 April 2023 | 55,765 |
| Additions | - |
| Disposals | - |
| At 31 March 2024 | 55,765 |
| Depreciation | |
| At 1 April 2023 | 48,375 |
| Charge for the period | 4,113 |
| On disposals | - |
| At 31 March 2024 | 52,488 |
| Net book value | |
| At 31 March 2024 | 3,278 |
| At 31 March 2023 | 7,391 |
21
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| 11. DEBTORS Due within one year Accrued Income Prepayments Other debtors |
Charity 2024 £ 7,716 13,755 6,627 28,098 |
Group 2024 £ 12,256 16,650 10,322 39,228 |
Charity 2023 £ 9,695 14,960 6,751 31,406 |
Group 2023 £ 56,579 19,318 10,740 |
|---|---|---|---|---|
| 86,637 |
| 12. CREDITORS: AMOUNTS FALLING DUE WITHIN Charity 2024 £ Funds held for partners - Trade creditors 1,824 Deferred Income 50,929 Funds held for Fair Trials Europe 27,835 Funds held for Fair Trials Americas - Accruals and other creditors 46,911 127,499 |
ONE YEAR Group 2024 £ 110,267 5,134 59,981 - 65,582 240,964 |
Charity 2023 £ 6,999 10,888 182,026 188,051 147,376 34,209 569,549 |
Group 2023 £ 348,371 11,659 557,499 - 58,011 |
|---|---|---|---|
| 975,540 |
Funds held for partners relate to both pre-payments on co-beneficiary grant amounts transferred to the Charity's bank account by the funder and still held at the year end and intercompany expenditure incurred by one entity on a grant relating to the other entity. The Charity co-ordinates the projects and is responsible for distributing pre-financing from the funder to the relevant beneficiaries but may not decide how the funds are allocated nor use the funds for its own project activities.
Funds held for Fair Trials Europe are the net funds due to the subsidiary at the year end and contains the following balances:
A one off grant of £81,271 awarded by the Charity to Fair Trials Europe in 2022/23 and £53,436 of net expentiture which the Charity has incurred on behalf of Fair Trials Europe. The total balance is £27,835 (2022/23: £188,051).
Funds held for Fair Trials Americas are the net funds due from the subsidiary at the year end and contains the following balances:
A one off grant of £53,051 awarded by the Charity to Fair Trials Americas in 2023/24 (2022/23: £187,762). This was paid during 2023/24 and so the total balance is £Nil (2022/23: £147,376).
22
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Deferred income Balance at 1 April 2023 Amount deferred in the year Balance at 31 March 2024 Amount released to incoming resources |
Charity 2024 £ 182,026 (182,026) 50,929 50,929 |
Group 2024 £ 557,499 (557,499) 59,981 59,981 |
Charity 2023 £ 15,557 (15,557) 182,026 182,026 |
Group 2023 £ 339,348 (339,348) 557,499 |
|---|---|---|---|---|
| 557,499 |
Deferred income comprises grants received which relate to activities to be completed in future periods.
23
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| 13. | STATEMENT OF FUNDS Year ended 31 March 2024 Brought Forward £ RESTRICTED FUNDS Open Society Foundations (Artificial Intelligence) - Stitching Digital Freedom Fund - Role UK - Index - Americas The Koch Foundation - Arnold Foundation - Mozilla Foundation - Europe Network of European Foundations: (AI in criminal justice) - Legal Experts Advisory Panel (LEAP) - Improving Judicial Assessment of Flight Risk (FLIGHTRISK) g g Trust in the European Justice Area (STREAM) - - |
Incoming Resources £ 109,546 13,431 13 2,795 54,092 2,150 8,968 51,858 156,775 29,626 1,840 431,092 |
Resources Expended £ (109,546) (13,431) (13) (2,795) - (54,092) (2,150) (8,968) - (51,858) (156,775) (29,626) (1,840) (431,092) |
Transfers £ - - - - - - - - - - - |
Carried Forward £ - - - - - - - - - - |
|---|---|---|---|---|---|
| - |
24
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Brought Forward £ SUMMARY OF FUNDS Subsidiary foundations 117,653 General Funds 196,771 314,424 Restricted - 314,424 |
Incoming Resources £ 1,830 475,612 477,442 431,092 908,534 |
Resources Expended £ (44,103) (510,548) (554,651) (431,092) (985,743) |
Transfers £ - - - - - |
Carried Forward £ 75,380 161,835 |
|---|---|---|---|---|
| 237,215 - |
||||
| 237,215 | ||||
| - |
All net assets relate to unrestricted funds (2022/23 all unrestricted).
Open Society Foundations (Artificial Intelligence)
A grant to advance strong safeguards for AI and big data applications in criminal justice systems in Europe.
Stitching Digital Freedom Fund
A grant supporting a case which involves an application to the Court of Justice of the European Union (CJEU) to consider the legality of actions by Europol, the European Union's law enforcement agency.
Role UK
Work to address the widespread use of torture and mistreatment that takes place in police custody in East Africa.
Freshfields Index
Grant to support creation of a global Fair Trails Country Index on procedural justice.
Koch Foundation (Fair Trials Americas)
A grant to expose the role plea bargaining plays in wider failings of the criminal justice system and identify and advance workable solutions.
Arnold Foundation (Fair Trials Americas)
A grant to examine the impact of stationhouse counsel, through insights into the variety of ways in which the legal right of access to counsel might be understood, the challenges and benefits associated with different models of represenation and identifying best practices.
Mozilla Foundation (Fair Trials Americas)
A grant examining AI-reliant systems and its potential uses, threats and challenges in Latin America.
Network of European Foundations: AI in criminal justice: protecting and empowering people’s rights (Fair Trials Europe)
A grant to research AI in criminal justice, to ensure that EU legislation contains strong safeguards, including the prohibition of the most harmful types of AI applications in policing and criminal justice systems; and that these safeguards are enforced at a national level.
25
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
European Union: Coordination of LEAP (Fair Trials Europe)
An operating grant to support the coordination of the Legal Experts Advisory Panel ("LEAP"). Individual LEAP members and other parties made donations to co-fund the cost of some LEAP activities.
European Commission: Improving Judicial Assessment of Flight Risk (Fair Trials Europe)
A partnership project, coordinated by Fair Trials Europe, to deeper understanding of the reality of judicial decision-making on pre-trial detention.
European Commission: Strengthening Trust in the European Criminal Justice Area STREAM (Fair Trials Europe)
A grant for a partnership project, coordinated by the Centre for European Policy Studies (CEPS), to strengthen trust in the European Criminal Justice Area through mutual recognition and the streamlined application of the European Arrest Warrant.
26
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Year ended 31 | |||||
|---|---|---|---|---|---|
| March 2023 | Brought | Incoming | Resources | Transfers | Carried |
| Forward | Resources | Expended | Forward | ||
| £ | £ | £ | £ | £ | |
| RESTRICTED FUNDS | |||||
| Open Society | |||||
| Foundations | |||||
| (Artificial | |||||
| Intelligence) | - | 48,267 | (48,267) | - | - |
| Porticus | - | 701 | (701) | - | - |
| Stitching Digital | |||||
| Freedom Fund | - | 13,362 | (13,362) | - | - |
| Clifford Chance | - | - | - | - | - |
| Role UK | - | 16,182 | (16,182) | - | - |
| Barrow Cadbury | - | 21,294 | (21,294) | - | - |
| UKRI | - | 1,140 | (1,140) | - | - |
| Freshfields | |||||
| Index | - | 26,276 | (26,276) | - | - |
| Americas | |||||
| The Koch | |||||
| Foundation | - | 86,534 | (86,534) | ||
| Arnold | |||||
| Foundation | - | 124,004 | (124,004) | ||
| Mary Jane & | |||||
| Associates | - | 24,873 | (24,873) | ||
| Irish Embassy - | |||||
| Mexico | - | 8,326 | (8,326) | ||
| Mozilla | |||||
| Foundation | - | 3,109 | (3,109) | ||
| Europe | |||||
| Network of | |||||
| European | |||||
| Foundations: (AI | |||||
| in criminal | |||||
| justice) | - | 10,138 | (10,138) | - | - |
| Legal Experts | |||||
| Advisory Panel | |||||
| (LEAP) | - | 176,390 | (176,390) | - | - |
27
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
| Brought Forward £ Improving Judicial Assessment of Flight Risk (FLIGHTRISK) - Litigating to Advance Defence Rights in Europe (LADRE) - Equality Data Collection (EQUALITYDAT A) - Strengthening Procedural Rights (PRO- RPC) - Strengthening Trust in the European Justice Area (STREAM) - - Brought Forward £ SUMMARY OF FUNDS Subsidiary founda 87,601 General Funds 265,989 353,590 Restricted Funds - 353,590 |
Incoming Resources £ 25,744 57,155 13,541 31,395 24,697 713,126 Incoming Resources £ 396,666 403,185 799,851 713,126 1,512,977 |
Resources Expended £ (25,744) (57,155) (13,541) (31,395) (24,697) 713,126 - Resources Expended £ (366,614) (472,403) (839,017) (713,126) (1,552,143) |
Transfers £ - - - - - - Transfers £ - - - - - |
Carried Forward £ - - - - - |
|---|---|---|---|---|
| - | ||||
| Carried Forward £ 117,653 196,771 |
||||
| 314,424 - |
||||
| 314,424 |
All net assets relate to unrestricted funds.
28
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
14. OTHER FINANCIAL COMMITMENTS
| Operating leases which expire: within one year within two to five years At 31 March 2024 the total of the Charity's future minimum lease payments under non-cancellable operating leases was as set out below: |
2024 £ 39,783 35,725 |
2023 £ 40,923 18,529 |
|---|---|---|
Operating lease commitments at 31 March 2024 were reviewed as part of the wind-up process. Leases were terminated, where applicable. The total termination costs, including lease break penalties, are included in Note 17.
15. RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES
| Net income for year Decrease / (increase) in debtors (Decrease) / Increase in creditors Net cash flow from operating activities Depreciation and impairment of tangible fixed assets Tangible fixed assets disposal |
Charity 2024 £ (34,936) 4,113 - 3,307 (442,050) (469,566) £ |
Group 2024 £ (77,209) 7,102 - 47,410 (734,578) (757,275) £ |
Charity 2023 £ 61,329 4,218 1,430 5,790 (368,102) (295,335) £ |
Group 2023 66,708 10,154 2,541 36,417 (546,649) |
|---|---|---|---|---|
| (430,829) £ |
||||
16. RELATED PARTY TRANSACTIONS
Unrestricted donations made by trustees in the year amounted to £NIL (2022/23: £500). Other than these amounts and balances and transactions referred to in Notes 8 and 12 regarding related foundations, there were no other related party transactions.
29
FAIR TRIALS INTERNATIONAL
NOTES TO THE FINANCIAL STATEMENTS For Year ended March 2024
17. Post balance sheet events
As of 31 March 2024, there was no decision or obligation to close the organization. The decision to commence the winding-up process for the Charity was made in September 2024, following a review of its financial and operational circumstances. This decision led to termination benefits, redundancy payments, and other wind-up costs incurred as part of the closure process. The Charity ceased all operational activities as of November 2024.
These costs have not been recognized in these financial statements as they arose from conditions that occurred after the reporting date. Instead, they will be accounted for in the financial statements for the subsequent reporting period. For transparency, the total estimated wind-up costs, including redundancy payments, legal fees, and contractual termination costs, amount to £57,871 and have been disclosed here.
After the reporting date, a former employee whose employment ended in June 2024 instituted a legal proceeding against the Charity. As the claim relates to events occurring after the reporting period, it has been classified as a non-adjusting post-balance sheet event. The Trustees are reviewing the claim with legal advisors to determine its validity and potential financial impact.
30